Global Implantable Cardioverter-Defibrillators (ICD) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Implantable Cardioverter-Defibrillators (ICD) market report explains the definition, types, applications, major countries, and major players of the Implantable Cardioverter-Defibrillators (ICD) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Boston Scientific Corporation (US)

    • St Jude Medical Inc (US)

    • Koninklijke Philips NV (Netherlands)

    • Nihon Kohden Corporation

    • Sorin Group

    • Medtronic PLC (Ireland)

    • BIOTRONIK SE & Co KG (Germany)

    • Medtronic Plc

    • PHILIPS HEALTHCARE

    • ZOLL Medical Corporation (US)

    By Type:

    • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)

    • Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)

    • Cardiac Resynchronization Therapy Defibrillator (CRT-D)

    By End-User:

    • ASCs

    • Hospital

    • Clinic

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Implantable Cardioverter-Defibrillators (ICD) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Implantable Cardioverter-Defibrillators (ICD) Outlook to 2028- Original Forecasts

    • 2.2 Implantable Cardioverter-Defibrillators (ICD) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Implantable Cardioverter-Defibrillators (ICD) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Implantable Cardioverter-Defibrillators (ICD) Market- Recent Developments

    • 6.1 Implantable Cardioverter-Defibrillators (ICD) Market News and Developments

    • 6.2 Implantable Cardioverter-Defibrillators (ICD) Market Deals Landscape

    7 Implantable Cardioverter-Defibrillators (ICD) Raw Materials and Cost Structure Analysis

    • 7.1 Implantable Cardioverter-Defibrillators (ICD) Key Raw Materials

    • 7.2 Implantable Cardioverter-Defibrillators (ICD) Price Trend of Key Raw Materials

    • 7.3 Implantable Cardioverter-Defibrillators (ICD) Key Suppliers of Raw Materials

    • 7.4 Implantable Cardioverter-Defibrillators (ICD) Market Concentration Rate of Raw Materials

    • 7.5 Implantable Cardioverter-Defibrillators (ICD) Cost Structure Analysis

      • 7.5.1 Implantable Cardioverter-Defibrillators (ICD) Raw Materials Analysis

      • 7.5.2 Implantable Cardioverter-Defibrillators (ICD) Labor Cost Analysis

      • 7.5.3 Implantable Cardioverter-Defibrillators (ICD) Manufacturing Expenses Analysis

    8 Global Implantable Cardioverter-Defibrillators (ICD) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Implantable Cardioverter-Defibrillators (ICD) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Implantable Cardioverter-Defibrillators (ICD) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Implantable Cardioverter-Defibrillators (ICD) Market Outlook by Types and Applications to 2022

    • 9.1 Global Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global ASCs Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Implantable Cardioverter-Defibrillators (ICD) Market Analysis and Outlook till 2022

    • 10.1 Global Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.2.2 Canada Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.2.3 Mexico Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.2 UK Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.3 Spain Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.4 Belgium Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.5 France Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.6 Italy Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.7 Denmark Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.8 Finland Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.9 Norway Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.10 Sweden Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.11 Poland Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.12 Russia Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.3.13 Turkey Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.2 Japan Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.3 India Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.4 South Korea Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.5 Pakistan Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.6 Bangladesh Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.7 Indonesia Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.8 Thailand Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.9 Singapore Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.10 Malaysia Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.11 Philippines Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.4.12 Vietnam Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.5.2 Colombia Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.5.3 Chile Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.5.4 Argentina Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.5.5 Venezuela Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.5.6 Peru Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.5.8 Ecuador Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.6.2 Kuwait Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.6.3 Oman Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.6.4 Qatar Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.7.2 South Africa Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.7.3 Egypt Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.7.4 Algeria Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

      • 10.8.2 New Zealand Implantable Cardioverter-Defibrillators (ICD) Consumption (2017-2022)

    11 Global Implantable Cardioverter-Defibrillators (ICD) Competitive Analysis

    • 11.1 Boston Scientific Corporation (US)

      • 11.1.1 Boston Scientific Corporation (US) Company Details

      • 11.1.2 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.1.4 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 St Jude Medical Inc (US)

      • 11.2.1 St Jude Medical Inc (US) Company Details

      • 11.2.2 St Jude Medical Inc (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 St Jude Medical Inc (US) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.2.4 St Jude Medical Inc (US) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Koninklijke Philips NV (Netherlands)

      • 11.3.1 Koninklijke Philips NV (Netherlands) Company Details

      • 11.3.2 Koninklijke Philips NV (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Koninklijke Philips NV (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.3.4 Koninklijke Philips NV (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Nihon Kohden Corporation

      • 11.4.1 Nihon Kohden Corporation Company Details

      • 11.4.2 Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.4.4 Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sorin Group

      • 11.5.1 Sorin Group Company Details

      • 11.5.2 Sorin Group Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sorin Group Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.5.4 Sorin Group Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Medtronic PLC (Ireland)

      • 11.6.1 Medtronic PLC (Ireland) Company Details

      • 11.6.2 Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.6.4 Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 BIOTRONIK SE & Co KG (Germany)

      • 11.7.1 BIOTRONIK SE & Co KG (Germany) Company Details

      • 11.7.2 BIOTRONIK SE & Co KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 BIOTRONIK SE & Co KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.7.4 BIOTRONIK SE & Co KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Medtronic Plc

      • 11.8.1 Medtronic Plc Company Details

      • 11.8.2 Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.8.4 Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 PHILIPS HEALTHCARE

      • 11.9.1 PHILIPS HEALTHCARE Company Details

      • 11.9.2 PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.9.4 PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 ZOLL Medical Corporation (US)

      • 11.10.1 ZOLL Medical Corporation (US) Company Details

      • 11.10.2 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

      • 11.10.4 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Implantable Cardioverter-Defibrillators (ICD) Market Outlook by Types and Applications to 2028

    • 12.1 Global Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global ASCs Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Implantable Cardioverter-Defibrillators (ICD) Market Analysis and Outlook to 2028

    • 13.1 Global Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.2 UK Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.5 France Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.3 India Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Implantable Cardioverter-Defibrillators (ICD)

    • Figure of Implantable Cardioverter-Defibrillators (ICD) Picture

    • Table Global Implantable Cardioverter-Defibrillators (ICD) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Implantable Cardioverter-Defibrillators (ICD) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) Consumption and Growth Rate (2017-2022)

    • Figure Global Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Consumption and Growth Rate (2017-2022)

    • Figure Global ASCs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Table North America Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Figure United States Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Canada Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Table Europe Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Figure Germany Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure UK Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Spain Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure France Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Italy Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Finland Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Norway Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Poland Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Russia Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Table APAC Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Figure China Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Japan Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure India Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Table South America Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Figure Brazil Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Chile Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Peru Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Table GCC Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Figure Bahrain Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Oman Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Table Africa Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Figure Nigeria Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Table Oceania Implantable Cardioverter-Defibrillators (ICD) Consumption by Country (2017-2022)

    • Figure Australia Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Implantable Cardioverter-Defibrillators (ICD) Consumption and Growth Rate (2017-2022)

    • Table Boston Scientific Corporation (US) Company Details

    • Table Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table St Jude Medical Inc (US) Company Details

    • Table St Jude Medical Inc (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table St Jude Medical Inc (US) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table St Jude Medical Inc (US) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table Koninklijke Philips NV (Netherlands) Company Details

    • Table Koninklijke Philips NV (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Koninklijke Philips NV (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table Koninklijke Philips NV (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table Nihon Kohden Corporation Company Details

    • Table Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table Sorin Group Company Details

    • Table Sorin Group Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorin Group Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table Sorin Group Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table Medtronic PLC (Ireland) Company Details

    • Table Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table BIOTRONIK SE & Co KG (Germany) Company Details

    • Table BIOTRONIK SE & Co KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BIOTRONIK SE & Co KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table BIOTRONIK SE & Co KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table Medtronic Plc Company Details

    • Table Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table PHILIPS HEALTHCARE Company Details

    • Table PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Table ZOLL Medical Corporation (US) Company Details

    • Table ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Main Business and Markets Served

    • Table ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Product Portfolio

    • Figure Global Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ASCs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Table North America Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Figure United States Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Figure Germany Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Figure China Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast by Country (2022-2028)

    • Figure Australia Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Implantable Cardioverter-Defibrillators (ICD) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.